Cargando…
Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice
BACKGROUND: Numerous studies indicate an association between neurodegenerative and metabolic diseases. Although still a matter of debate, growing evidence from epidemiological and animal studies indicate that preexisting diabetes increases the risk to develop Parkinson's disease. However, the m...
Autores principales: | Pérez‐Taboada, Iara, Alberquilla, Samuel, Martín, Eduardo D., Anand, Rishi, Vietti‐Michelina, Stefania, Tebeka, Nchimunya N., Cantley, James, Cragg, Stephanie J., Moratalla, Rosario, Vallejo, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818508/ https://www.ncbi.nlm.nih.gov/pubmed/32666590 http://dx.doi.org/10.1002/mds.28124 |
Ejemplares similares
-
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
por: Bayliss, Jacqueline A., et al.
Publicado: (2016) -
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017) -
Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016) -
Calbindin-D28K Limits Dopamine Release in Ventral
but Not Dorsal Striatum by Regulating Ca(2+) Availability
and Dopamine Transporter Function
por: Brimblecombe, Katherine R., et al.
Publicado: (2019) -
Inhibition of Nigrostriatal Dopamine Release by Striatal GABA(A) and GABA(B) Receptors
por: Lopes, Emanuel F., et al.
Publicado: (2019)